BrainsWay Ltd. (BWAY)
undefined
undefined%
At close: undefined
9.42
-0.42%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally.

It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.

The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry.

Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.
BrainsWay Ltd. logo
Country IL
IPO Date Apr 17, 2019
Industry Medical - Devices
Sector Healthcare
Employees 134
CEO Hadar Levy

Contact Details

Address:
Bynet Building
Jerusalem,
IL
Website https://www.brainsway.com

Stock Details

Ticker Symbol BWAY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001505065
CUSIP Number 10501L106
ISIN Number US10501L1061
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Hadar Levy Chief Executive Officer
Gilead Moiseyev Chief Technology Officer
Ido Marom Chief Financial Officer
Avner Hagai Founder & Director
Dr. Richard A. Bermudes M.D. Chief Medical Officer
Dr. Yiftach Roth Ph.D. Founder & Chief Scientific Officer
Hillegonda Groen Vice President of International Sales
Menachem C. Klein Esq. Vice President, General Counsel & Corporate Secretary
Prof. Abraham Zangen Co-Founder, Member of Scientific Advisory Board & Director
Ross Mitchell Vice President of Global Marketing

Latest SEC Filings

Date Type Title
Dec 12, 2024 6-K Filing
Nov 20, 2024 6-K Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 13, 2024 SC 13D Filing
Nov 05, 2024 6-K Filing
Oct 15, 2024 D Filing
Oct 09, 2024 6-K Filing
Oct 01, 2024 6-K Filing
Sep 30, 2024 6-K Filing